|
rs2900174
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
|
28470677 |
2017 |
|
rs763780
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.
|
28470677 |
2017 |
|
rs11141915
|
|
T |
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.
|
22293537 |
2012 |
|
rs11141915
|
|
T |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.
|
22293537 |
2012 |
|
rs2900174
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
|
22142827 |
2012 |
|
rs2900174
|
|
G |
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
|
22142827 |
2012 |
|
rs763780
|
|
G |
0.800 |
GeneticVariation |
GWASDB |
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
|
22142827 |
2012 |
|
rs763780
|
|
G |
0.800 |
GeneticVariation |
GWASCAT |
A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
|
22142827 |
2012 |
|
rs121912578
|
|
C |
0.800 |
CausalMutation |
CLINVAR |
|
|
|
|
rs121912578
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
|
|
|
|
rs401681
|
|
T |
0.740 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
|
rs505922
|
|
C |
0.740 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
|
rs401681
|
|
|
0.740 |
GeneticVariation |
GWASCAT |
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
|
26098869 |
2015 |
|
rs505922
|
|
|
0.740 |
GeneticVariation |
GWASCAT |
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
|
26098869 |
2015 |
|
rs401681
|
|
T |
0.740 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
|
20101243 |
2010 |
|
rs505922
|
|
C |
0.740 |
GeneticVariation |
GWASCAT |
We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
|
19648918 |
2009 |
|
rs121913529
|
|
A |
0.740 |
CausalMutation |
CLINVAR |
|
|
|
|
rs121913529
|
|
T |
0.740 |
CausalMutation |
CLINVAR |
|
|
|
|
rs3790844
|
|
A |
0.730 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
|
rs3790844
|
|
T |
0.730 |
GeneticVariation |
GWASCAT |
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
|
20101243 |
2010 |
|
rs11655237
|
|
T |
0.720 |
GeneticVariation |
GWASCAT |
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
|
26098869 |
2015 |
|
rs13303010
|
|
G |
0.710 |
GeneticVariation |
GWASCAT |
Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
|
29422604 |
2018 |
|
rs1517037
|
|
C |
0.710 |
GeneticVariation |
GWASCAT |
Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
|
29422604 |
2018 |
|
rs1561927
|
|
T |
0.710 |
GeneticVariation |
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
|
rs2941471
|
|
A |
0.710 |
GeneticVariation |
GWASCAT |
Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PANDoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10<sup>-14</sup>), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10<sup>-10</sup>), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10<sup>-8</sup>), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10<sup>-8</sup>). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA.
|
29422604 |
2018 |